Global Cardiac Marker Market Projected to Grow at 13% CAGR, Reaching $20.35 Billion by 2029

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Cardiac Marker Industry Market Size Be by 2025?
The size of the cardiac marker market has seen a quick expansion in recent years. It's set to increase from $11.26 billion in 2024 to $12.47 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. Factors contributing to the growth during the past period include the rising prevalence of cardiovascular diseases, the ageing of the population and the risks of cardiovascular diseases, as well as the implementation of awareness programs and health screenings, the inclusion of biomarkers in clinical practice, and the adherence to strict regulatory standards and guidelines.

What's the Long-Term Growth Forecast for the Cardiac Marker Market Size Through 2029?
In the coming years, a swift expansion is expected for the cardiac marker market, which is predicted to reach a value of ""$20.35 billion in 2029, expanding at a compound annual growth rate (CAGR) of 13.0%. This growth over the forecast period can be credited to the increasing prevalence of lifestyle-linked illnesses, the implementation of remote monitoring and telemedicine, personalized medicine and precision diagnoses, as well as the adoption of point-of-care testing (poct). Additionally, notable trends for the forecast period involve the discovery and verification of biomarkers, the application of personalized medicine strategies, technological development in assay platforms, the inclusion of high-sensitivity troponin tests and an increase in the prevalence of cardiovascular diseases.

View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

What Are the Key Growth Drivers Fueling the Cardiac Marker Market Expansion?
The acceleration of cardiac diseases is predicted to stimulate the expansion of the cardiac marker market. Cardiac diseases encapsulate a variety of conditions impacting the heart's structure or function and result in numerous health issues. Cardiac markers come in handy for diagnosing and tracking multiple heart conditions such as heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the need for diagnostic exams or cardiac markers is on the rise. For example, the British Heart Foundation, a cardiovascular research charity based in the UK, reported that England had experienced 30,000 additional deaths due to coronary heart diseases from the outbreak of the pandemic till August 2022. A staggering 346,000 individuals were on a cardiac waiting list as of the end of August 2022. Hence, the increasing occurrence of cardiac diseases is set to drive the growth of the cardiac marker market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

What Are the Key Trends Driving Cardiac Marker Market Growth?
The cardiac marker market is seeing a rise in the trend of product innovation. Large market participants are concentrating on creating novel solutions to consolidate their standing in the market. For example, in September 2022, MiRxes, a biotechnology company hailing from Singapore, confirmed the effectiveness of a diagnostic test based on microRNA technology, intended for early detection and diagnosis of diseases. Upon its commercialization, this test is set to boost MiRxes' assortment of blood tests for cancer, providing a comprehensive set of early detection measures. This strategy aims to mitigate the growing clinical and socioeconomic impacts of severe diseases, including cancer and cardio-pulmonary disorders.

How Is the Cardiac Marker Market Segmented?
The cardiac marker market covered in this report is segmented -

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers
2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA
3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications
4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:
1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits
2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels
3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels
4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Which Companies Are Leading the Charge in Cardiac Marker Market Innovation?
Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

Which Regions Are Leading the Global Cardiac Marker Market in Revenue?
North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Contact Us:
The Business Research Company
Europe - +44 7882 955267
Asia: +91 88972 63534
Americas - +1 310-496-7795
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.